RSS icon

eSolutions Q&A

  •   Are the benefits of integrating IVR systems with other study management tools truly being realized, or do companies have a lot more kinks to work out in that area?

    Whilst such integrated services are relatively new to the industry, the acceptance of the concept and adoption of such integrated solutions is gaining momentum in the marketplace. Seamless data integration and interoperability between IVR systems and other study management tools is being developed as a direct response to sponsor and user requests to streamline the entire clinical trials management process. The main challenge for the industry is not with the technology associated service integration but more with the large number of systems and external processes that a successful solution must integrate with. The successful organization in this market place will be the one which focuses on the user and their relationship with the data moving around the integrated environment.

  •   Has investigator acceptance of electronically managed drug accountability documentation caught up with their comfort level in other trial technologies, such as EDC?

    For clients using EDA in an ongoing manner, sites are absolutely comfortable with the electronic process as it simplifies the workflow and centralizes all drug accountability information. Electronic drug accountability hasn’t yet had the widespread use that EDC now enjoys, so it is difficult to generalize any comparisons to EDC. However we are seeing good adoption and few issues in studies that are using it.